Return On Equity of Coeptis Therapeutics Holdings, Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Coeptis Therapeutics Holdings, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Coeptis Therapeutics Holdings, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -186%, a 83% increase year-over-year.
  • Coeptis Therapeutics Holdings, Inc. annual Return On Equity for 2024 was -588%, a 62% increase from 2023.
  • Coeptis Therapeutics Holdings, Inc. annual Return On Equity for 2023 was -1543%.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Coeptis Therapeutics Holdings, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -186% +883% +83% 01 Jul 2025 30 Sep 2025
Q2 2025 -215% +4925% +96% 01 Apr 2025 30 Jun 2025
Q1 2025 -282% +1568% +85% 01 Jan 2025 31 Mar 2025
Q4 2024 -588% +955% +62% 01 Oct 2024 31 Dec 2024
Q3 2024 -1070% -176% -20% 01 Jul 2024 30 Sep 2024
Q2 2024 -5140% 01 Apr 2024 30 Jun 2024
Q1 2024 -1850% 01 Jan 2024 31 Mar 2024
Q4 2023 -1543% 01 Oct 2023 31 Dec 2023
Q3 2023 -894% 01 Jul 2023 30 Sep 2023
Q3 2021 7% 01 Jul 2021 30 Sep 2021
Q2 2021 51% 01 Apr 2021 30 Jun 2021
Q1 2021 43% 01 Jan 2021 31 Mar 2021
Q4 2020 315% 01 Oct 2020 31 Dec 2020

Coeptis Therapeutics Holdings, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -588% +955% +62% 01 Jan 2024 31 Dec 2024
2023 -1543% 01 Jan 2023 31 Dec 2023
2020 315% 01 Jan 2020 31 Dec 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.